M. Caricato et al. / Tetrahedron 68 (2012) 7861e7866
7865
4.3. General procedure for the UV/vis or CD titration
experiments
25 ꢂC)
d
¼8.17 (s, 2H; H500), 8.11 (s, 2H; H4), 7.92 (dt, 2H; J¼8.1,
0.7 Hz, H8), 7.62 (m, 2H; H20), 7.78 (d, 4H; J¼8.0 Hz, H2000), 7.74 (ddd,
2H; J¼7.6, 2.2, 1.4 Hz, H60), 7.53 (part of an ABX system, 2H;
JAB¼7.6 Hz, JAX¼7.6 Hz, H50), 7.50 (part of an ABX2 system, 2H;
JAB¼7.6 Hz, JAX¼1.4 Hz, H40), 7.40 (ddd, 2H; J¼8.1, 6.9, 1.5 Hz, H7),
7.26 (d, 4H; J¼8.0 Hz, H3000), 7.20e7.25 (m, 2H, H6), 7.16e7.19 (m,
2H, H5), 4.94 and 4.88 (AB system, 4H; JAB¼12.4 Hz, BinoleCH2),
4.82 (s, 4H; benzyliceCH2), 3.28 (s, 6H; OCH3), 2.40 (s, 6H; CH3)
Methylcyclohexane (MCH) was purchased as UV/vis spectro-
scopic grade and used as received. An analytical balance (with
a precision of 10ꢀ4 g) was used to weight the samples for the stock
solutions. Aliquots of these stock solutions were then taken via high
precision syringes to prepare the cuvette samples for spectropho-
tometric analyses. Titration experiments. The titration experiments
were conducted as follows: to a stock solution of the host (solution
A) in CH2Cl2 or MCH/CH2Cl2, several aliquots of the guest (the
tetrabutylammonium salt, solution B) were added. Solution B is
formed by the tetrabutylammonium salt at higher concentration
dissolved in solution A, in order to maintain the host always at
a constant concentration.
ppm; 13C NMR (CDCl3, 125 MHz, 25 ꢂC)
d
¼154.7, 140.6, 138.3, 137.3,
134.0, 131.3, 130.5, 129.8 (C50), 129.6 (C3000), 129.2 (C4), 128.1 (C8),
127.8 (C40), 127.4 (Cq), 126.5 (C6), 125.7 (C200), 125.6 (C5), 125.0 (C7),
124.4 (Cq),119.7 (C60),119.6 (C20),117.3 (C500), 72.0 (BinoleCH2), 68.4
(benzyliceCH2), 61.1 (OCH3), 21.3 (CH3). MS (ESI) m/z (%): 891
([MþNa]þ, 23), 869.0 ([MþH]þ, 100).
4.5.3. Macrocycle (R)-7. 1,8-Diazabicyclo[5.4.0]undec-7-ene (742 mg,
4.88 mmol, 20 equiv) was dissolved in dry toluene (100 mL) and N2
was bubbled through the solution for 15 min. The solution was
heated at 70 ꢂC for 30 min and CuI (23 mg, 0.122 mmol, 0.5 equiv) was
added as a solid. A solution of compound (R)-3 (155 mg, 0.244 mmol,
1 equiv) and 1,3-diethynylbenzene 5 (31 mg, 0.244 mmol, 1 equiv) in
dry toluene (40 mL) was added dropwise over a period of 10 h while
keeping the reaction mixture under inert atmosphere. The reaction
was stirred at room temperature for 4 h. H2O (100 mL) was added and
the reaction mixture extracted with CH2Cl2 (3ꢄ100 mL). The product
was purified by flash chromatography (SiO2; hexanes/AcOEt: 9/1 to 7/
3) to afford (R)-6 (58 mg, 31%) as a white solid [found C 75.5, H 5.3.
4.4. Molecular modelling
The conformational analysis of (R)-6 or (R)-7 and their com-
plexes were carried out with the classical molecular mechanics
force field (MMFF) by using the Monte Carlo method to randomly
sample the conformational space. The equilibrium geometry
obtained for the minimum-energy conformer (R)-6 or (R)-7 was
refined at the PM3 semi-empirical level. The equilibrium geometry
of the complexes were calculated using the molecular mechanics
force field from the optimized geometry of the receptor, by placing
the anion(s) at a short distance from the triazole CH hydrogen
atoms and leaving the system free to relax without constraints. The
conformer obtained was further refined by semi-empirical
methods at the PM3 level. All calculations were performed using
Spartan’10 (Wavefunction, Inc., Irvine, CA).20
C48H38N6O4 requires C 75.6, H 5.0%]; ½a D25
ꢀ11.6 (c 0.001 in CH2Cl2).
ꢃ
1H NMR (CDCl3, 500 MHz, 25 ꢂC)
d
¼8.28 (s, 2H; H500), 8.21 (dd, 2H;
J¼7.6, 1.3 Hz, H4000), 8.11 (s, 2H; H4), 7.97 (ddd, 2H; J¼7.9, 2.0, 1.1 Hz,
H40), 7.89 (dd, 2H; J¼8.1, 1.3 Hz, H8), 7.71 (br s, 1H; H2000), 7.62 (br s,
2H; H20), 7.59 (t, 1H; J¼7.6 Hz, H5000), 7.56 (t, 2H; J¼7.9 Hz, H50), 7.50
(dt, 2H; J¼7.9, 1.1 Hz, H60), 7.37 (ddd, 2H; J¼8.1, 6.7, 1.3 Hz, H7), 7.21
(ddd, 2H; J¼8.6, 6.7, 1.3 Hz, H6), 7.15 (dd, 2H; J¼8.6, 1.3 Hz, H5), 4.96
and 4.87 (AB system, 4H; J¼11.6 Hz, benzyliceCH2), 4.85 and 4.79 (AB
system, 4H; J¼12.1 Hz, BinoleCH2), 3.27 (s, 6H; CH3) ppm; 13C NMR
4.5. Synthesis of compounds
4.5.1. Compound (R)-3. Compound (R)-1 (0.303 g, 0.81 mmol,
1 equiv) was added to a solution of NaH (0.088 g, 3.64 mmol,
4.5 equiv) in THF/DMF 3:1 (20 mL). A solution of 2 (0.429 g,
2.02 mmol, 2.5 equiv) in THF (3 mL) was then added. The suspen-
sion was stirred overnight and H2O (5 mL) was added. The THF was
removed in vacuo, then the mixed aqueous layer was extracted
with CH2Cl2 (3ꢄ15 mL). The crude product was purified by flash
chromatography (SiO2; hexanes/AcOEt: 95/5 to 8/2) to afford 3
(164 mg, 32%) as a white solid; [found: C 71.5, H 5.0. C38H32N6O4
(CDCl3, 125 MHz, 25 ꢂC)
d
¼154.8, 147.8, 140.1, 137.1, 134.0, 131.1, 2ꢄ
130.5, 130.2 (2C, C4), 130.1 (3C, C50 and C5000), 130.0, 128.6 (C60), 128.1
(C8),126.6 (C6),126.2 (C4000), 125.6 (C5), 125.1 (C7), 124.5, 123.3 (C2000),
121.0 (CH-40), 119.7 (C20), (C60), 118.3 (C500), 72.6 (BinoleCH2), 68.8
(benzyliceCH2), 61.4 (OCH3). MS (ESI) m/z (%): 785.3 ([MþNa]þ, 100),
1548.1 ([2MþNa]þ, 28).
requires C 71.7, H 5.1%]; ½a D25
ꢃ
ꢀ25.9 (c 0.007, CH2Cl2). 1H NMR
Acknowledgements
(CDCl3, 300 MHz, 25 ꢂC)
d
¼8.13 (s, 2H; H4 binaphthyl), 7.94 (d, 2H;
J¼8.1 Hz, binaphthyl), 7.45e7.18 (m, 12H; binaphthylþAreH), 7.21
(m, 4H; binaphthyl), 7.01 (d, 2H; J¼7.8 Hz, AreH), 4.91 (AB system,
4H; J¼12.4 Hz, CH2), 4.76 (s, 4H; CH2), 3.30 (s, 6H; eOCH3). 13C NMR
Support from the University of Pavia, University of
Messina, MIUR (Programs of National Relevant Interest PRIN
grants 2004-033354 and 2009-A5Y3N9), and, in part, from CAR-
IPLO Foundation (2007e2009) and INSTM-Regione Lombardia
(2010e2012), is gratefully acknowledged.
(CDCl3, 75 MHz, 25 ꢂC)
d
¼154.6 (Cq), 140.4 (Cq), 140.2 (Cq), 133.9
(Cq), 131.4 (Cq), 130.4 (Cq), 129.7 (CH), 128.9 (CH), 128.0 (CH), 126.3
(CH), 125.6 (CH), 124.8 (CH), 124.3 (Cq), 124.1 (CH), 118.2 (CH), 118.1
(CH), 72.2 (CH2), 68.2 (CH2), 61.0 (OCH3). MS (ESI) m/z (%): 659
([MþNa]þ, 100), 1294 ([2MþNa]þ, 6).
Supplementary data
Supplementary data contain additional NMR, UV and CD spec-
tra, titrations and computational details associated with this article.
Supplementary data related to this article can be found online at
4.5.2. Compound (R)-6. Compound (R)-3 (34 mg, 0.053 mmol,
1 equiv) was added to a solution of 4-ethynyltoluene 4 (0.014 mL,
0.106 mmol, 2 equiv), sodium
L-(þ)-ascorbate (2 mg, 0.0106 mmol,
0.2 equiv) and CuSO4 (1 mg, 0.0053 mmol, 0.1 equiv) in EtOH/H2O/
toluene 7:3:1 (1.1 mL). The homogeneous solution was stirred for
48 h at room temperature. The solution was partitioned into two
layers by adding CH2Cl2, and the aqueous layer was extracted with
clean CH2Cl2 (3ꢄ5 mL). The combined organic layers were dried
(Na2SO4), and the product was purified by flash chromatography
(SiO2; hexanes/AcOEt: 9/1 to 7/3) to afford (R)-6 (31 mg, 77%) as
a white solid [found C 77.5, H 5.3. C56H48N6O4 requires C 77.4, H
References and notes
1. de Silva, A. P.; Gunaratne, H. Q. N.; Gunnlaugsson, T.; Huxley, A. J. M.; McCoy, C.
P.; Rademacher, J. T.; Rice, T. E. Chem. Rev. 1997, 97, 1515e1566.
2. (a) Berova, N.; Di Bari, L.; Pescitelli, G. Chem. Soc. Rev. 2007, 36, 914e931; (b)
Hembury, G. A.; Borovkov, V. V.; Inoue, Y. Chem. Rev. 2008, 108, 1e73.
3. For a review: (a) Canary, J. W.; Mortezaei, S.; Liang, J. Coord. Chem. Rev. 2010,
254, 2249e2266 See also: (b) Moletti, A.; Coluccini, C.; Pasini, D.; Taglietti, A.
Dalton Trans. 2007, 16, 1588e1592.
5.6%]; ½a 2D5
ꢃ
ꢀ18.1 (c 0.005 in CH2Cl2). 1H NMR (CDCl3, 500 MHz,